Sodium Phenylbutyrate is primarily used as an alternative therapy for patients suffering from urea cycle disorders. It helps to breakdown nitrogen-containing waste substances in the body. The product provides an effective treatment option and minimizes health complications associated with urea cycle disorders. With increasing cases of urea cycle disorders worldwide, the demand for sodium phenylbutyrate is augmenting at a significant pace.

The global Sodium Phenylbutyrate Market is estimated to be valued at US$ 1.92 Bn in 2023 and is expected to exhibit a CAGR of 4.2% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.

Market key trends:
The rising prevalence of urea cycle disorders is a key driver enhancing the growth prospects of the sodium phenylbutyrate market. Urea cycle disorders are a group of rare genetic metabolic disorders characterized by deficiencies of synthesis of key urea cycle enzymes. According to data released by the National Institutes of Health, the estimated prevalence of urea cycle disorders is 1 in 35,000 newborns in the United States. Early diagnosis and proper treatment are crucial to minimize health complications related to urea cycle disorders. Physicians often prescribe sodium phenylbutyrate as an adjunct therapy for managing elevated levels of ammonia in patients diagnosed with urea cycle disorders. Thus, increasing awareness regarding urea cycle disorders and their available treatment options is expected to aid the market growth over the forecast period.

Segment Analysis
The global sodium phenylbutyrate market can be segmented based on type, application and region. By type, the sodium phenylbutyrate granule segment is expected to dominate the market during the forecast period. Sodium phenylbutyrate granules are easy to administer and have high patient acceptability compared to powder form, which makes it the dominating sub-segment.

Key Takeaways
The Global Sodium Phenylbutyrate Market Demand is expected to witness high growth during the forecast period.

Regional analysis: North America is currently the largest as well as the fastest growing regional market. Factors such as the presence of major players and increasing prevalence of urea cycle disorders are contributing to the growth of sodium phenylbutyrate market in the region.

Key players operating in the sodium phenylbutyrate market are Procter & Gamble (P&G) Chemicals, CREMER, Wilmar, VVF Ltd., KLK OLEO, Inoue Perfumery MFG, Wuhan Yuancheng Gongchuang, Changsha Jianglong Chemicals, Godrej Industries. These players are focusing on new product launches and mergers & acquisitions to strengthen their position in the market. For instance, in 2020, Procter & Gamble (P&G) Chemicals expanded its production capacity for sodium phenylbutyrate in the US to meet the growing demand.

Explore more information on this topic, Please visit @ https://www.marketwebjournal.com/increasing-prevalence-of-urea-cycle-disorders-share